𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide

✍ Scribed by Qing Jiang; Xiayu Rao; Choon Young Kim; Helene Freiser; Qingbo Zhang; Ziying Jiang; Guilan Li

Book ID
102864332
Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
789 KB
Volume
130
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Although cell‐based studies have shown that γ‐tocotrienol (γTE) exhibits stronger anticancer activities than other forms of vitamin E including γ‐tocopherol (γT), the molecular bases underlying γTE‐exerted effects remains to be elucidated. Here we showed that γTE treatment promoted apoptosis, necrosis and autophagy in human prostate PC‐3 and LNCaP cancer cells. In search of potential mechanisms of γTE‐provoked effects, we found that γTE treatment led to marked increase of intracellular dihydroceramide and dihydrosphingosine, the sphingolipid intermediates in de novo sphingolipid synthesis pathway but had no effects on ceramide or sphingosine. The elevation of these sphingolipids by γTE preceded or coincided with biochemical and morphological signs of cell death and was much more pronounced than that induced by γT, which accompanied with much higher cellular uptake of γTE than γT. The importance of sphingolipid accumulation in γTE‐caused fatality was underscored by the observation that dihydrosphingosine and dihydroceramide potently reduced the viability of both prostate cell lines and LNCaP cells, respectively. In addition, myriosin, a specific inhibitor of de novo sphingolipid synthesis, counteracted γTE‐induced cell death. In agreement with these cell‐based studies, γTE inhibited LNCaP xenograft growth by 53% (p < 0.05), compared to 33% (p = 0.07) by γT, in nude mice. These findings provide a molecular basis of γTE‐stimulated cancer cell death and support the notion that elevation of intracellular dihydroceramide and dihydrosphingosine is likely a novel anticancer mechanism.

📜 SIMILAR VOLUMES

Pristimerin induces apoptosis by targeti
Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells
✍ Huanjie Yang; Kristin R. Landis-Piwowar; Dayan Lu; Ping Yuan; Lihua Li; G. Prem- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Pristimerin is a natural product derived from the __Celastraceae__ and __Hippocrateaceae__ families that were used as folk medicines for antiinflammation in ancient times. Although it has been shown that pristimerin induces apoptosis in breast cancer cells, the involved mechanism of act

Mitotic catastrophe and apoptosis induce
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells
✍ Francesco Fabbri; Dino Amadori; Silvia Carloni; Giovanni Brigliadori; Anna Tesei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Studies performed in different experimental and clinical settings have shown that Docetaxel (Doc) is effective in a wide range of tumors and that it exerts its activity through multiple mechanisms of action. However, the sequence of events induced by Doc which leads to cell death is sti

Sequence- and schedule-dependent enhance
Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells
✍ Helen L. Neville-Webbe; Amin Rostami-Hodjegan; Catherine A. Evans; Robert E. Col 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB 👁 1 views

## Abstract We investigated whether the combination of zoledronic acid and doxorubicin induced apoptosis of breast and prostate cancer cell lines, and if synergistic interaction was present. We investigated whether the levels of cell death altered depending on the sequence in which the drugs were a